Melatonin for Sleep and Circadian Rhythm

The single most useful thing to understand about melatonin and sleep is that it is a timing signal, not a sedative. It does not push you into unconsciousness the way a sleeping pill does; it tells your brain that biological night has begun, and lets your own sleep machinery follow. That is why melatonin shines for problems of timing — a body clock running late (delayed sleep phase), the shrinking natural output of older adults, the free-running rhythms of totally blind people — and underwhelms as a general knock-out drug for ordinary insomnia. The honest effect sizes from the large meta-analyses are modest: roughly seven minutes faster to fall asleep and a similar bump in total sleep. This page explains what melatonin genuinely does for sleep, where the evidence is strong, where it is weak, and how to use timing to get the most from it.

Table of Contents

1. A Chronobiotic, Not a Sleeping Pill
2. What the Meta-Analyses Actually Show
3. The Body Clock, DLMO, and Why Timing Rules
4. Delayed Sleep Phase (Night Owls)
5. Older Adults and Declining Melatonin
6. Non-24-Hour Rhythm in Blind People
7. Where Melatonin Underperforms
8. Combining Melatonin with Sleep Habits and CBT-I
9. Practical Use for Better Sleep Timing
10. Key Research Papers
11. Connections
12. Featured Videos

A Chronobiotic, Not a Sleeping Pill

Prescription hypnotics such as zolpidem or the benzodiazepines act on the brain's GABA system to directly dampen arousal — they sedate. Melatonin works on a completely different principle. Circulating melatonin binds MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), the brain's master clock, and elsewhere. The MT1 signal modestly reduces the SCN's daytime "stay awake" drive, and the MT2 signal shifts the phase (timing) of the clock. The net message is not "sleep now by force" but "it is night; align accordingly."

This is why researchers call melatonin a chronobiotic — an agent that moves the body clock — rather than a hypnotic. A useful mental model: a sleeping pill is like switching off the lights in a room; melatonin is like moving the hands of the clock on the wall so the whole house acts as if night has come. When the underlying problem is that the clock is set wrong, melatonin is exactly the right tool. When the problem is racing thoughts, pain, or hyperarousal in someone whose clock is already correct, melatonin has much less to offer.

Back to Table of Contents

What the Meta-Analyses Actually Show

Several large meta-analyses have pooled the randomized trials of melatonin for sleep, and the honest bottom line is statistically real but clinically modest:

• Ferracioli-Oda and colleagues (2013, PLoS One) pooled 19 studies of primary sleep disorders. Melatonin reduced the time to fall asleep (sleep-onset latency) by about 7 minutes, increased total sleep time by about 8 minutes, and improved overall sleep quality. The sleep-quality improvement was consistent across studies even though the time numbers were small.
• Brzezinski and colleagues (2005, Sleep Medicine Reviews) found melatonin cut sleep-onset latency by roughly 4 minutes, raised sleep efficiency by about 2 percentage points, and lengthened total sleep by around 13 minutes.
• Buscemi and colleagues (2005, Journal of General Internal Medicine), an evidence review commissioned for a US federal agency, concluded the effect on sleep-onset latency was small and of uncertain clinical significance for most primary insomnia, while noting a better signal for circadian-timing disorders.

Put plainly: for a healthy adult with garden-variety insomnia, melatonin will not reliably deliver the dramatic sedation of a prescription hypnotic. What it does do — consistently — is nudge sleep earlier and improve subjective sleep quality, with a safety profile far gentler than any sedative. And the numbers understate its value in the specific groups discussed below, where the problem is the timing.

Back to Table of Contents

The Body Clock, DLMO, and Why Timing Rules

Every day, before your natural bedtime, your own melatonin begins to rise — an event called the dim light melatonin onset (DLMO). DLMO is the gold-standard marker of your internal clock's phase, and it typically occurs about two hours before habitual sleep. The DLMO is the anchor for using melatonin correctly.

The pivotal insight came from Alfred Lewy and colleagues, who mapped melatonin's phase-response curve (PRC) in humans (1992 and later work). The same dose of melatonin can shift your clock earlier or later depending on when you take it:

• Taken in the late afternoon or early evening (before your DLMO), melatonin advances the clock — it moves sleepiness earlier, helping night owls fall asleep sooner.
• Taken in the morning, melatonin delays the clock — useful in rare cases of advanced sleep phase (falling asleep and waking far too early).
• Taken close to your natural bedtime, the timing effect is small; you mostly get the mild sleep-promoting nudge, not a big phase shift.

This is the crux of the whole topic: with melatonin, when you take it can matter more than how much you take. A tiny dose at the right circadian time outperforms a large dose at the wrong time. The Dosing & Safety page develops this point in detail, and the Jet Lag & Shift Work page applies the phase-response curve to travel.

Back to Table of Contents

Delayed Sleep Phase (Night Owls)

Delayed sleep-wake phase disorder (DSWPD) is the clearest win for melatonin. People with DSWPD — disproportionately adolescents and young adults — have a body clock set several hours late. Left alone they might not feel sleepy until 3 a.m. and would naturally wake near midday. That is fine on vacation and disastrous on a school or work schedule, producing chronic sleep deprivation that masquerades as insomnia.

A meta-analysis by van Geijlswijk and colleagues (2010, Sleep) confirmed that low-dose melatonin, taken in the evening several hours before the person's spontaneous (late) sleep time, advances the DLMO and moves sleep onset earlier. The key clinical points:

• The dose is small — commonly 0.5 to 1 mg. Higher doses do not advance the clock better and are more likely to cause next-day grogginess.
• Timing is everything. Melatonin is taken roughly 3–5 hours before current (delayed) sleep onset, i.e. before the DLMO — not at the desired new bedtime.
• It works best paired with a gradually earlier schedule and, in the morning, bright light exposure to reinforce the advance.

Because DSWPD is fundamentally a timing disorder, this is melatonin operating in its natural mode. For related sleeplessness that is not a timing disorder, see the site's Insomnia resource.

Back to Table of Contents

Older Adults and Declining Melatonin

Natural melatonin output falls with age. The pineal gland calcifies over the decades, and nighttime melatonin levels in many people over 55 are a fraction of what they were in youth. This is one reason older adults commonly report lighter, more fragmented sleep and earlier waking. It also makes older adults one of the groups most likely to respond to supplemental melatonin, because they may genuinely be replacing something they have lost.

Two influential lines of evidence:

• Zhdanova and colleagues (2001) showed that in older adults with insomnia, physiologic doses of melatonin (as low as 0.3 mg) restored more normal sleep, and that pushing to higher doses gave no additional benefit — and could produce daytime carry-over. This is a foundational study behind the "low dose is enough" principle.
• Prolonged-release melatonin (marketed in Europe as Circadin, 2 mg) was designed to mimic the natural overnight melatonin curve rather than a single spike. Trials by Wade and colleagues (2007) and Lemoine and colleagues (2007) in patients aged 55 and older found improved sleep quality and morning alertness, with no withdrawal effects on stopping. On this basis prolonged-release melatonin is licensed as a short-term prescription treatment for primary insomnia in adults 55+ in the UK, the EU, and elsewhere.

The practical message for older adults: a small dose, taken about an hour before the desired bedtime, is a reasonable and low-risk first thing to try, particularly when the complaint is difficulty falling asleep at a normal bedtime.

Back to Table of Contents

Non-24-Hour Rhythm in Blind People

The most striking demonstration that melatonin is a true clock-setting hormone comes from totally blind people. Without light reaching the retina, the SCN cannot be reset each morning, so the clock "free-runs" on its natural period — usually a little longer than 24 hours. The result is non-24-hour sleep-wake disorder: sleep drifts progressively later day by day, cycling in and out of alignment with the outside world over weeks.

Timed melatonin can substitute for the missing light cue, entraining (locking) the free-running clock to a stable 24-hour day. This is not a subjective sleep-quality effect — it is objective re-synchronization of the entire circadian system, documented by tracking each person's own melatonin rhythm. It is arguably the purest proof that exogenous melatonin genuinely moves the human clock, and it underpins the approved use of melatonin-receptor agonists for non-24 in the blind.

Back to Table of Contents

Where Melatonin Underperforms

Honesty requires naming the situations where melatonin is a poor choice:

• Sleep-maintenance insomnia (waking at 3 a.m. and not getting back to sleep) responds less well to standard immediate-release melatonin than sleep-onset problems, because a quick-release dose is largely cleared within a few hours.
• Hyperarousal insomnia — a racing mind, anxiety, or stress in a person whose clock is set correctly — is not a timing problem, so melatonin's timing action is beside the point.
• Pain, restless legs, sleep apnea, and depression disrupt sleep through mechanisms melatonin does not touch. Melatonin will not fix them and can delay proper diagnosis if used as a catch-all.
• Expecting hypnotic-strength sedation. People who compare melatonin head-to-head with a prescription sleeping pill are often disappointed — that is the wrong yardstick. Melatonin's advantage is not potency; it is safety and its unique ability to shift timing.

If insomnia is chronic (three or more nights a week for three or more months), the first-line treatment recommended by sleep medicine is not any pill but cognitive behavioral therapy for insomnia (CBT-I), discussed next.

Back to Table of Contents

Combining Melatonin with Sleep Habits and CBT-I

Melatonin is most effective as one part of a coherent approach to the body clock, not as a standalone fix:

• Light is the stronger lever. The clock is set far more powerfully by light than by melatonin. Getting bright light (ideally outdoor daylight) soon after waking, and dimming lights and screens in the last hour or two before bed, does more to advance a delayed clock than melatonin alone. Melatonin and morning light work in the same direction and reinforce each other.
• Consistent wake time anchors the whole system. A fixed rise time, seven days a week, stabilizes the clock so melatonin has something to align to.
• CBT-I — stimulus control, sleep restriction, and cognitive work on sleep-related anxiety — is the evidence-based first-line treatment for chronic insomnia and outperforms sleep medication over the long term. Melatonin can be a useful adjunct, particularly where there is a timing component, but it is not a substitute for CBT-I.
• Address the obvious saboteurs: late caffeine, alcohol (which fragments sleep), and evening screen light (which suppresses your own melatonin at exactly the wrong time).

Calming botanicals and amino acids are sometimes combined with melatonin for the hyperarousal component; see L-Theanine, Valerian, Passionflower, and Magnesium. These target arousal, whereas melatonin targets timing — a complementary pairing rather than duplication.

Back to Table of Contents

Practical Use for Better Sleep Timing

Synthesizing the evidence into practical guidance (general education, not a prescription — discuss with a clinician, especially if you take other medicines):

1. Start low. 0.5–1 mg is a reasonable starting point for most timing purposes. More is not better and raises the odds of morning grogginess.
2. To fall asleep earlier (advance a late clock): take the small dose in the early evening, a few hours before your current (late) sleep time — not at your desired new bedtime. Pair with bright light in the morning.
3. For a normal-bedtime nudge (e.g. older adults): take it about 30–60 minutes before the desired bedtime.
4. Be patient and consistent. Circadian shifts accrue over several nights; a single dose is not a fair test for a timing problem.
5. Keep the room dark after dosing. Bright light — including phone screens — after taking melatonin works against it.
6. Reassess. If insomnia is chronic and not a timing problem, pursue CBT-I and rule out apnea, restless legs, pain, and mood disorders rather than escalating the melatonin dose.

Back to Table of Contents

Key Research Papers

1. Ferracioli-Oda E, Qureshi IA, Bloch MH (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. — PubMed
2. Brzezinski A, Vangel MG, Wurtman RJ, et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews. — PubMed
3. Buscemi N, Vandermeer B, Hooton N, et al. (2005). The efficacy and safety of exogenous melatonin for primary sleep disorders: a meta-analysis. Journal of General Internal Medicine. — PubMed
4. van Geijlswijk IM, Korzilius HPLM, Smits MG (2010). The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. — PubMed
5. Lewy AJ, Ahmed S, Latham Jackson JM, Sack RL (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiology International. — PubMed
6. Zhdanova IV, Wurtman RJ, Regan MM, et al. (2001). Melatonin treatment for age-related insomnia. Journal of Clinical Endocrinology & Metabolism. — PubMed
7. Wade AG, Ford I, Crawford G, et al. (2007). Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years. Current Medical Research and Opinion. — PubMed
8. Lemoine P, Nir T, Laudon M, Zisapel N (2007). Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older. Journal of Sleep Research. — PubMed
9. Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews. — PubMed
10. Arendt J, Skene DJ (2005). Melatonin as a chronobiotic. Sleep Medicine Reviews. — PubMed
11. Zisapel N (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology. — PubMed

PubMed Topic Searches

• PubMed: Melatonin and delayed sleep phase
• PubMed: Melatonin phase-response curve / DLMO
• PubMed: Melatonin and non-24 in the blind
• PubMed: Prolonged-release melatonin in older adults
• PubMed: Low physiologic-dose melatonin

Back to Table of Contents

External Authoritative Resources

• NIH NCCIH — Melatonin: What You Need To Know
• American Academy of Sleep Medicine — circadian rhythm sleep-wake disorder guidelines
• MedlinePlus — Melatonin

Back to Table of Contents

Connections

• Melatonin (Main Page)
• Melatonin Benefits Hub
• Melatonin for Jet Lag & Shift Work
• Melatonin Dosing & Safety
• Insomnia
• Tryptophan (Precursor)
• L-Theanine
• Magnesium
• Valerian
• Passionflower
• Lemon Balm
• Chamomile
• Anxiety
• All Antioxidants

Back to Table of Contents

Featured Videos